Fosun Pharma: Net profit is expected to increase by 21.69% year-on-year in 2025.

Fosun Pharmaceutical announced that the company's operating income in 2025 is 41.662 billion yuan, a year-on-year increase of 1.45%; The net profit attributable to the shareholders of the listed company in 2025 is 3.371 billion yuan, a year-on-year increase of 21.69%.